Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists  Por  arte de portada

Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists

De: Annenberg Center for Health Sciences
  • Resumen

  • In this activity, case studies commonly encountered in cardiology practice are utilized to prompt reflection on opportunities for reducing cardiovascular risk. Drawing on seminal research and their own experience, cardiologist Jorge Plutzy, MD, and endocrinologist Helena Rodbard, MD, navigate through a series of ‘clinical questions’ to inform regarding the clinical pharmacology of the GLP-1RAs and their evidence-based role in cardiovascular risk reduction, particularly in patients with secondary atherosclerotic cardiovascular disease.
    Annenberg Center for Health Sciences
    Más Menos
activate_primeday_promo_in_buybox_DT
Episodios
  • Cardiologist Collaboration
    Mar 5 2024
    • Role in Diabetes Management
    • Multidisciplinary Team-based Approach
    Más Menos
    5 m
  • Individualizing Therapy
    Mar 5 2024
    • Drug Initiation and Monitoring
    • Contraindications and Adverse Effects
    • Patient Education
    Más Menos
    8 m
  • Cardiovascular Benefits
    Mar 5 2024
    • FDA Indications
    • Clinical Trial Evidence

    Más Menos
    4 m

Lo que los oyentes dicen sobre Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.